Randomised, Double-blind Parallel Group Study to Assess the Bronchodilative and Bronchoprotective Properties of SERETIDE DISKUS ® Inhlaer 50/100mcg Twice Daily vs. FLIXOTIDE® Inhaler 200mcg Twice Daily
Latest Information Update: 17 Jul 2023
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 15 Oct 2008 Actual start date changed from Oct 2003 to Jan 2003 as reported by ClinicalTrials.gov
- 09 Nov 2007 Status changed from recruiting to completed
- 27 Nov 2005 New trial record.